SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAbrdn Di&g Regulatory News (ADIG)

  • This share is currently suspended. It was suspended at a price of 13.33

Share Price Information for Abrdn Di&g (ADIG)

Share Price is delayed by 15 minutes
Get Live Data
13.33    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: £40.16m
ADIG Live PriceLast checked at - London Stock Exchange

Intraday Abrdn Di&g Share Chart

Apportionment Ratio for Nov 2025 B share issue

8 Jan 2026 13:59

RNS Number : 2184O
abrdn Diversified Income and Growth
08 January 2026
 

abrdn Diversified Income and Growth plc

Legal Entity Identifier (LEI): 2138003QINEGCHYGW702

 

8 January 2026

Apportionment Ratio for B share issue November 2025

 

Further to Part 5 of the Circular to shareholders published on 17 June 2024 (the "Circular"), abrdn Diversified Income and Growth plc (the "Company") announces the apportionment ratio in relation to the B shares issued in November 2025. The Circular may be found on the Company's website (https://www.abrdndiversified.co.uk/en-gb).

 

For the purposes of United Kingdom taxation of capital gains and corporation tax on chargeable gains ("Capital Gains Tax"), the issue of B Shares constitutes a reorganisation of the share capital of the Company. Accordingly, the B Shares are treated as the same asset as a shareholder's holding of existing Ordinary shares, and as having been acquired at the same time as a shareholder's holding of existing Ordinary shares was acquired. A shareholder's combined holding of Ordinary shares and B shares has the same aggregate base cost as the shareholder's holding of Ordinary shares immediately before the issue of B shares. The aggregate base cost should be apportioned between B shares and the Ordinary shares held by a shareholder by reference to the market values of the Ordinary shares and the B shares on the first day of trading after the issue of B shares.

 

Due to the terms on which the B Shares were issued and subsequently redeemed, and as they were unlisted and non-transferable, their market value has been assessed, below, as equal to their nominal value of one pence on 14 November 2025. The market value of the Ordinary shares is calculated with reference to their market value on the first day of trading after the issue of the B shares, which is considered to be 14 November 2025.

Accordingly, the aggregate base cost of the Ordinary shares which should be apportioned against the B Shares redemption proceeds, received by shareholders on or about 21 November 2025, is 41.30%, calculated as follows:

 

Class of share

Market value on first day of trading

(pence per share)

Relevant ratio used for the issue of B Shares

Relevant value (pence per share)

Relevant percentage

Ordinary share*

27

1

27

58.70%

B Share

1

19

19

41.30%

 

* The lower of the two prices for an Ordinary share shown in the London Stock Exchange Daily Official List for 14 November 2025 as the closing price for an Ordinary share on that day plus one-half of the difference between those two figures in accordance with SI 2015/616.

 

United Kingdom taxation

The information above does not constitute tax advice and is intended only as a guide to United Kingdom law and HMRC published practice (which are both subject to change at any time, possibly with retrospective effect). It relates only to certain limited aspects of the United Kingdom taxation treatment of shareholders and is intended to apply only to shareholders who are resident in the United Kingdom for United Kingdom tax purposes and who are, and were the absolute beneficial owners of their Ordinary shares and B Shares and who hold, or held, them as investments (and not as securities to be realised in the course of a trade) other than under an

ISA. The information above may not apply to certain shareholders, such as, but not limited to, dealers in securities, insurance companies, collective investment schemes and shareholders who are exempt from taxation. The position may be different for future transactions.

 

Shareholders who are in any doubt as to their tax position or who are subject to tax in a jurisdiction other than the United Kingdom should consult an appropriate professional adviser.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FURBXGDBUUGDGLI
Date   Source Headline
1st May 20269:44 amRNSUpdate on First Distribution
23rd Apr 20267:00 amRNSFirst distribution in Liquidation
30th Mar 20262:58 pmRNSResult of General Meeting
27th Mar 202611:21 amRNSReplace - Apportionment Ratio - Feb 2026 B shares
25th Mar 20266:00 pmRNSABRDN Diversified Income and Growth
18th Mar 20263:42 pmRNSApportionment Ratio for Feb 2026 B share issue
11th Mar 20267:02 amRNSCircular and Notice of General Meeting
11th Mar 20267:00 amRNSUpdate on Managed Wind-Down
5th Mar 20267:00 amRNSInterim Dividend
11th Feb 20267:00 amRNSB Share Scheme Distribution
5th Feb 20269:35 amRNSHolding(s) in Company
4th Feb 20267:00 amRNSUpdate on Managed Wind-Down
23rd Jan 20267:00 amRNSChange of Corporate Broker
19th Jan 202611:19 amRNSDoc re. Half Yearly Report
8th Jan 20261:59 pmRNSApportionment Ratio for Nov 2025 B share issue
8th Jan 202612:53 pmRNSMonth End Net Asset Value(s)
8th Jan 20267:00 amRNSManaged Wind-Down Update
6th Jan 202611:26 amRNSQuarterly disclosure
22nd Dec 20253:42 pmRNSMonth End Net Asset Value(s)
19th Dec 202512:00 pmRNSHalf-year Financial Report
19th Dec 202512:00 pmRNSHalf-year Financial Report
18th Dec 20253:00 pmRNSUpdate on Managed Wind Down
18th Dec 20253:00 pmRNSUpdate on Managed Wind Down
6th Nov 20251:47 pmRNSMonth End Net Asset Value(s)
29th Oct 20257:00 amRNSB Share Scheme Distribution
10th Oct 20257:00 amRNSMonth End Net Asset Value(s)
2nd Oct 20254:38 pmRNSQuarterly disclosure
1st Oct 202510:38 amRNSUpdate on Managed Wind-Down
30th Sep 202512:32 pmRNSNet Asset Value(s)
29th Sep 202512:34 pmRNSNet Asset Value(s)
26th Sep 202511:39 amRNSNet Asset Value(s)
25th Sep 202512:26 pmRNSNet Asset Value(s)
25th Sep 20259:30 amRNSInterim Dividend
24th Sep 202512:35 pmRNSNet Asset Value(s)
23rd Sep 202511:33 amRNSNet Asset Value(s)
22nd Sep 202512:17 pmRNSNet Asset Value(s)
19th Sep 202510:48 amRNSNet Asset Value(s)
18th Sep 20252:12 pmRNSHolding(s) in Company
18th Sep 202511:20 amRNSNet Asset Value(s)
17th Sep 202511:46 amRNSNet Asset Value(s)
16th Sep 202510:56 amRNSNet Asset Value(s)
15th Sep 202511:30 amRNSNet Asset Value(s)
12th Sep 202512:05 pmRNSNet Asset Value(s)
11th Sep 202511:44 amRNSNet Asset Value(s)
10th Sep 202511:40 amRNSNet Asset Value(s)
9th Sep 202510:53 amRNSNet Asset Value(s)
8th Sep 202512:04 pmRNSNet Asset Value(s)
5th Sep 202512:22 pmRNSNet Asset Value(s)
4th Sep 20252:59 pmRNSMonth End Net Asset Value(s)
4th Sep 202511:05 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.